The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABLYNX NV | SPONSORED ADR | 00372Y905 | 4,910 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| ACHILLION PHARMACEUTICALS INC | COM | 00448Q201 | 4,063 | 1,095,100 | SH | SOLE | 1,095,100 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS | COM | 00847X104 | 10,631 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| AMAG PHARMACEUTICALS INC | COM | 00163UAA4 | 8,463 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONSORED ADR | 023111206 | 5,252 | 1,745,000 | SH | SOLE | 1,745,000 | 0 | 0 | ||
| ARDELYX | COM | 039697107 | 5,734 | 1,135,600 | SH | SOLE | 1,135,600 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 5,709 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 62,597 | 1,715,000 | SH | SOLE | 1,715,000 | 0 | 0 | ||
| BIOFRONTERA AG | SPONSORED ADS | 090758105 | 6,462 | 391,200 | SH | SOLE | 391,200 | 0 | 0 | ||
| BIOLINERX LTD | SPONSORED ADR | 09071M106 | 214 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES | COM | 09627Y109 | 55,020 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 3,120 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 18,706 | 1,700,600 | SH | SOLE | 1,700,600 | 0 | 0 | ||
| CORIUM INTERNATIONAL INC | COM | 21887L107 | 12,215 | 1,065,000 | SH | SOLE | 1,065,000 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 8,638 | 665,000 | SH | SOLE | 665,000 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS INC | COM | 24344T101 | 7,314 | 365,000 | SH | SOLE | 365,000 | 0 | 0 | ||
| DEPOMED INC | COM | 249908104 | 3,954 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| EPIZYME INC | COM | 29428V104 | 1,242 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 10,559 | 873,000 | SH | SOLE | 873,000 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 16,632 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 4,873 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
| FORTRESS BIOTECH INC | COM | 34960Q109 | 1,433 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | ||
| LOXO ONCOLOGY | COM | 548862101 | 20,697 | 179,400 | SH | SOLE | 179,400 | 0 | 0 | ||
| MIRAGEN THERAPEUTICS INC | COM | 60463E10E | 7,430 | 1,060,000 | SH | SOLE | 1,060,000 | 0 | 0 | ||
| OCULAR THERAPEUTIX INC | COM | 67576A900 | 7,232 | 1,111,000 | SH | SOLE | 1,111,000 | 0 | 0 | ||
| PROTALIX BIOTHERAPEUTICS INC | COM | 74365A101 | 1,760 | 3,260,000 | SH | SOLE | 3,260,000 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 3,923 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
| QUANTERIX CORP | COM | 74766Q101 | 2,556 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| QUOTIENT LTD | SHS | G73268107 | 282 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| SANGAMO BIOSCIENCES INC | COM | 800677106 | 10,165 | 535,000 | SH | SOLE | 535,000 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | COM | G85347105 | 14,071 | 1,590,000 | SH | SOLE | 1,590,000 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 3,166 | 222,500 | SH | SOLE | 222,500 | 0 | 0 | ||
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 961 | 74,074 | SH | SOLE | 74,074 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 3,893 | 274,200 | SH | SOLE | 274,200 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICALS INC | COM | 90400D108 | 4,079 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 4,810 | 1,100,800 | SH | SOLE | 1,100,800 | 0 | 0 | ||
| XOMA CORP DEL | COM NEW | 98419J206 | 6,477 | 320,200 | SH | SOLE | 320,200 | 0 | 0 | ||
| ZOSANO PHARMA CORP | COM | 98979H103 | 504 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||